We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.06B
AUM Growth
+$11.1M
Cap. Flow
-$39M
Cap. Flow %
-3.69%
Top 10 Hldgs %
18.29%
Holding
2,111
New
638
Increased
394
Reduced
467
Closed
537

Sector Composition

Rank Sector Weight
1 Technology 18.22%
2 Healthcare 13.36%
3 Communication Services 10.32%
4 Consumer Discretionary 7.52%
5 Industrials 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAD
1176
PUT
DELISTED
Rite Aid Corporation
RAD
$27K ﹤0.01%
455
+100
+28% +$7.56K
ARRY
1177
DELISTED
Array Biopharma Inc
ARRY
$27K ﹤0.01%
+3,276
New +$26.8K
ABEV icon
1178
PUT
Ambev
ABEV
$47B
$26K ﹤0.01%
+4,800
New +$27.4K
AGX icon
1179
Argan
AGX
$8.69B
$26K ﹤0.01%
+426
New +$27.5K
BZH icon
1180
Beazer Homes USA
BZH
$910M
$26K ﹤0.01%
+1,900
New +$24.6K
CHCO icon
1181
City Holding Co
CHCO
$2.06B
$26K ﹤0.01%
+400
New +$26.5K
RIGL icon
1182
Rigel Pharmaceuticals
RIGL
$723M
$26K ﹤0.01%
969
+489
+102% +$13.4K
SRI icon
1183
Stoneridge
SRI
$211M
$26K ﹤0.01%
1,679
-3,721
-69% -$62.4K
COHR
1184
DELISTED
Coherent Inc
COHR
$26K ﹤0.01%
+114
New +$26.2K
CA
1185
DELISTED
CA, Inc.
CA
$26K ﹤0.01%
761
-45,615
-98% -$1.48M
NDRM
1186
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$26K ﹤0.01%
+876
New +$22.7K
BURL icon
1187
Burlington
BURL
$23.3B
$25K ﹤0.01%
270
-1,200
-82% -$115K
DSX icon
1188
Diana Shipping
DSX
$309M
$25K ﹤0.01%
+8,673
New +$25.2K
ENTA icon
1189
Enanta Pharmaceuticals
ENTA
$385M
$25K ﹤0.01%
704
-2,031
-74% -$65K
GRMN
1190
Garmin
GRMN
$59.5B
$25K ﹤0.01%
496
-4,204
-89% -$215K
ODC icon
1191
Oil-Dri
ODC
$1.42B
$25K ﹤0.01%
1,200
ULBI icon
1192
Ultralife
ULBI
$91.4M
$25K ﹤0.01%
+3,538
New +$21.7K
UPBD icon
1193
Upbound Group
UPBD
$1.21B
$25K ﹤0.01%
+2,100
New +$23.7K
LSXMK
1194
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$25K ﹤0.01%
+788
New +$23.6K
GEN
1195
DELISTED
Genesis Healthcare, Inc.
GEN
$25K ﹤0.01%
14,500
+9,300
+179% +$19.8K
SINA
1196
DELISTED
Sina Corp
SINA
$25K ﹤0.01%
300
-1,700
-85% -$143K
ENOV icon
1197
Enovis
ENOV
$1.78B
$24K ﹤0.01%
+349
New +$23.8K
ES icon
1198
Eversource Energy
ES
$27.3B
$24K ﹤0.01%
395
-2,602
-87% -$158K
OSK icon
1199
Oshkosh
OSK
$9.63B
$24K ﹤0.01%
350
-683
-66% -$46K
ISEE
1200
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$24K ﹤0.01%
+9,200
New +$25.1K

Similar funds

Prelude Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Prelude Capital Management held 2,111 positions worth $1.06B, up 1.1% from $1.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Prelude Capital Management withdrew a net $39M in Q2 2017, closing 537 positions and reducing 467 holdings. Its most notable exit was The WhiteWave Foods Company, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Prelude Capital Management opened a new position in Altaba Inc worth $16.4M.

  • Prelude Capital Management's largest Q2 2017 buy was Altaba Inc: 301,001 shares worth $16.4M.
  • Prelude Capital Management added most to CR Bard Inc. in Q2 2017, an estimated $24.5M increase.
  • Prelude Capital Management's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $9.34M.
  • Prelude Capital Management fully exited The WhiteWave Foods Company in Q2 2017, selling an estimated $13.3M.
  • Prelude Capital Management's ten largest holdings make up 18% of its $1.06B portfolio in Q2 2017.
  • Prelude Capital Management opened 638 new positions and closed 537 in Q2 2017.
  • Prelude Capital Management's portfolio value rose 1.1% quarter-over-quarter to $1.06B.

Based on Prelude Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.